Related Experiment Video
Updated: Sep 16, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Immunosuppressive Tumor Microenvironment of Osteosarcoma.
Aaron Michael Taylor1, Jianting Sheng2, Patrick Kwok Shing Ng1
1The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Osteosarcoma research reveals an immunosuppressive tumor microenvironment. Key interactions involve myeloid-derived suppressor cells and regulatory T cells, hindering effective therapies for this pediatric bone cancer.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Osteosarcoma is the most common pediatric bone cancer.
- It exhibits high genomic instability but lacks defining mutations.
- Current therapies have shown limited improvement over 40 years.
Purpose of the Study:
- To investigate the immune microenvironment of osteosarcoma.
- To identify cellular subtypes and their interactions.
- To understand mechanisms contributing to treatment resistance.
Main Methods:
- Single-cell RNA sequencing of 12 osteosarcoma samples.
- Spatial transcriptomics for subtype validation and spatial context.
- Cell-cell communication modeling.
Main Results:
- Identification of immunosuppressive cells: myeloid-derived suppressor cells (MDSCs), regulatory T cells, exhausted T cells, and LAMP3+ dendritic cells.
- MDSCs interact with other cells, upregulating NF-κB and creating an immunosuppressive environment.
- Regulatory T cells and osteosarcoma cells interact to promote tumor progression and angiogenesis.
Conclusions:
- Osteosarcoma possesses a complex, immunosuppressive immune microenvironment.
- Interactions involving MDSCs and regulatory T cells are critical drivers of tumor progression.
- Targeting these cellular interactions may offer novel therapeutic strategies for osteosarcoma.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy